Display Settings:

Format

Send to:

Choose Destination
    Breast Cancer Res. 2005;7(3):96-9. Epub 2005 Apr 1.

    Microarrays and breast cancer clinical studies: forgetting what we have not yet learnt.

    Source

    Cancer Genomics Programme, Department of Oncology, University of Cambridge, Hutchison/MRC Research Centre, Cambridge, UK.

    Abstract

    This review takes a sceptical view of the impact of breast cancer studies that have used microarrays to identify predictors of clinical outcome. In addition to discussing general pitfalls of microarray experiments, we also critically review the key breast cancer studies to highlight methodological problems in cohort selection, statistical analysis, validation of results and reporting of raw data. We conclude that the optimum use of microarrays in clinical studies requires further optimisation and standardisation of methodology and reporting, together with improvements in clinical study design.

    PMID:
    15987437
    [PubMed - indexed for MEDLINE]
    PMCID: PMC1143564
    Free PMC Article

    Images from this publication.See all images (1) Free text

    Figure 1

      Supplemental Content

      Click here to read Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk